GHK-CU Dosage Calculator | Peptide Reconstitution Tool

 🇺🇸 USA 2-DAY SHIPPING | FREE SHIPPING OVER $120 |🇺🇸 USA 2-DAY SHIPPING | FREE SHIPPING OVER $120 | 🇺🇸 USA 2-DAY SHIPPING | FREE SHIPPING OVER $120 |

 🇺🇸 USA 2-DAY SHIPPING | FREE SHIPPING OVER $120 |🇺🇸 USA 2-DAY SHIPPING | FREE SHIPPING OVER $120 | 🇺🇸 USA 2-DAY SHIPPING | FREE SHIPPING OVER $120 |

GHK-Cu
(Copper Peptide) Calculator

This GHK-Cu dosage calculator estimates syringe units, concentration, vial yield, and how long a vial will last based on vial size, water volume, and amount per dose

Common GHK-Cu parameters are pre-selected for faster calculation.

Looking for a specific peptide?

Go to peptide-specific calculator ↓

Result

To have a dose of 1mg pull the syringe to 0

10 20 30 40 50 60 70 80 90 100

Your vial contains

0.0 doses

Concentration

0.0 mg/mL

Your vial will last

Select Your Specific Peptide

Reconstitution guide

Use our Peptide Calculator below to calculate accurate dosages foradministering peptides using a syringe.

STEP 1

Set your dose

Choose your intended dose in micrograms (mcg): This is the amount of peptide you plan to inject each time.

STEP 2

Enter your peptide strength

Enter the peptide strength in your vial. You can select a common amount, such as 1mg, 5mg, 10mg, or 15mg. If your amount isn’t listed, you can manually type in the exact amount. 

STEP 3

Add your water volume

The volume of water you add affects the concentration of the peptide solution. Enter the amount of water in milliliters (mL). 

GHK-Cu Calculator Dosage: What the research says

This information is based on preclinical and clinical research studies. GHK-Cu Calculator is not FDA-approved for human use. This content is for research and informational purposes only

Common Research Doses
  • Low (1.0mg / 1000mcg): Often utilized in conservative or localized skin remodeling trials, where lower concentrations effectively stimulate basal cell regeneration, elastin production, and fibroblast activity.[1]
  • Mid (2.5mg / 2500mcg): The standard median dosage in systemic literature, frequently cited in in vivo protocols observing significant upregulation of angiogenesis, collagen synthesis, and the modulation of systemic inflammatory pathways.[2]
  • High (5.0mg / 5000mcg): The upper threshold typically reserved for severe acute injury models, such as accelerated burn/scald wound healing, or larger animal models requiring a robust systemic delivery of the copper-peptide complex.[3]
Frequency of Administration

In experimental systemic protocols, GHK-Cu is most commonly administered once daily. For localized wound-healing or continuous dermatological models, researchers aim to maintain a stable, uninterrupted concentration of the copper-peptide complex to continuously signal matrix metalloproteinases and attract immune cells to the site of injury.[1]

Route of Administration
  • Subcutaneous (SubQ): The standard route for in vivo systemic research targeting generalized anti-inflammatory markers or widespread soft tissue repair. Note: Due to the chemical nature of the copper chelate, researchers often utilize higher reconstitution volumes (e.g., 2ml or 3ml of bacteriostatic water) or co-administer with compounds like BPC-157 to mitigate localized post-injection irritation (PIP) frequently observed with this specific peptide.
  • Topical / Transdermal: Highly documented in dermatological research, as the low-molecular-weight GHK-Cu complex effectively penetrates the stratum corneum to stimulate local collagen, decorin, and glycosaminoglycan synthesis in the dermal matrix.[2]
Study Duration

GHK-Cu research generally follows both sub-acute and longitudinal timelines depending on the tissue remodeling goals:

  • Wound Healing & Acute Repair: 2 to 4 weeks is the standard timeline for observing accelerated angiogenesis, enhanced blood vessel formation, and macroscopic wound closure in severe injury models.[3]
  • Longitudinal Skin / Anti-aging Models: 8 to 12 weeks for observing sustained upregulation of structural proteins and the restoration of replicative vitality in aged or radiation-damaged fibroblasts.[1]
Evidence Limitations

While decades of in vitro and animal models demonstrate GHK-Cu’s profound ability to accelerate tissue remodeling, attract immune cells, and modulate inflammatory pathways, it is not approved by the FDA as an injectable therapeutic for wound healing, anti-aging, or systemic inflammation in humans. All data provided is strictly for educational context, and all compounds are restricted to Research Use Only (RUO).

Scientific References
  1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
  2. Dou Y, Lee A, Poon L, et al. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2(1):58-61. https://pmc.ncbi.nlm.nih.gov/articles/PMC8789089/
  3. Wang X, Liu B, Xu Q, et al. GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis. Wound Repair Regen. 2017;25(2):270-278. https://pubmed.ncbi.nlm.nih.gov/28370978/